{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2011-N-0003\" sorted by posted_date descending", "rows": [["FDA-2011-N-0003-0081", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-324 Phenylpropanolamine", "Supporting & Related Material", "Freedom of Information Summary", "2012-03-19T04:00:00Z", 2012, 3, null, null, "2012-03-19T19:03:24Z", null, 0, 0, "0900006480fdb2bc"], ["FDA-2011-N-0003-0080", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-331 Pergolide", "Supporting & Related Material", "Freedom of Information Summary", "2012-03-19T04:00:00Z", 2012, 3, null, null, "2012-03-19T16:43:41Z", null, 0, 0, "0900006480fda89d"], ["FDA-2011-N-0003-0079", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Phenylpropanolamine", "Rule", "Final Rule", "2012-03-19T04:00:00Z", 2012, 3, "2012-03-19T04:00:00Z", null, "2012-03-19T16:36:30Z", "2012-06553", 0, 0, "0900006480fdac8f"], ["FDA-2011-N-0003-0078", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Pergolide", "Rule", "Final Rule", "2012-03-19T04:00:00Z", 2012, 3, "2012-03-19T04:00:00Z", null, "2012-03-19T13:39:39Z", "2012-06544", 0, 0, "0900006480fdac97"], ["FDA-2011-N-0003-0077", "FDA", "FDA-2011-N-0003", "Animal Drugs, Feeds, and Related Products: N-Methyl-2-Pyrrolidone; Correction", "Rule", "Correction", "2012-02-17T05:00:00Z", 2012, 2, "2012-02-17T05:00:00Z", null, "2012-02-17T14:12:13Z", "2012-03747", 0, 0, "0900006480fb8faf"], ["FDA-2011-N-0003-0076", "FDA", "FDA-2011-N-0003", "FDA/DDM Courtesy Letter to the Holders of Applications - Letter", "Other", "Letter(s)", "2012-02-16T05:00:00Z", 2012, 2, "2012-02-16T05:00:00Z", null, "2012-02-16T23:45:05Z", null, 0, 0, "0900006480fac666"], ["FDA-2011-N-0003-0075", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor; Chlortetracycline Powder", "Rule", null, "2012-02-06T05:00:00Z", 2012, 2, "2012-02-06T05:00:00Z", null, "2012-02-06T17:48:19Z", "2012-02633", 0, 0, "0900006480fae382"], ["FDA-2011-N-0003-0073", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Chloramphenicol, Diethylcarbamazine Citrate, Hygromycin B, Methoxyflurane, Neomycin Sulfate, Penicillin G, Phenylbutazone,etc.", "Rule", "Final Rule", "2012-02-01T05:00:00Z", 2012, 2, "2012-02-01T05:00:00Z", null, "2012-02-01T15:16:51Z", "2012-02103", 0, 0, "0900006480faacf8"], ["FDA-2011-N-0003-0074", "FDA", "FDA-2011-N-0003", "Withdrawal of Approval of New Animal Drug Applications", "Notice", "General Notice", "2012-02-01T05:00:00Z", 2012, 2, "2012-02-01T05:00:00Z", null, "2012-02-01T15:47:20Z", "2012-02109", 0, 0, "0900006480faacba"], ["FDA-2011-N-0003-0063", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary ANDA 200-494 - Gentamicin Sulfate", "Supporting & Related Material", "Freedom of Information Summary", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:18:17Z", null, 0, 0, "0900006480fa722e"], ["FDA-2011-N-0003-0067", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-207 - Danofloxacin", "Supporting & Related Material", "Freedom of Information Summary", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:33:04Z", null, 0, 0, "0900006480fa7232"], ["FDA-2011-N-0003-0062", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Gentamicin Sulfate", "Rule", "Final Rule", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:11:48Z", "2012-01753", 0, 0, "0900006480fa6f59"], ["FDA-2011-N-0003-0065", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-322 - Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate", "Supporting & Related Material", "Freedom of Information Summary", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:24:50Z", null, 0, 0, "0900006480fa7230"], ["FDA-2011-N-0003-0069", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 095-735 - Monensin", "Supporting & Related Material", "Freedom of Information Summary", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T15:00:40Z", null, 0, 0, "0900006480fa729f"], ["FDA-2011-N-0003-0071", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Milbemycin Oxime, Lufenuron, and Praziquantel", "Rule", "Final Rule", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T15:09:20Z", "2012-01744", 0, 0, "0900006480fa7022"], ["FDA-2011-N-0003-0064", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate", "Rule", "Final Rule", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:20:52Z", "2012-01754", 0, 0, "0900006480fa6f61"], ["FDA-2011-N-0003-0072", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel", "Supporting & Related Material", "Reference (internal unless indicated)", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T15:12:54Z", null, 0, 0, "0900006480fa72a3"], ["FDA-2011-N-0003-0068", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Monensin", "Rule", "Final Rule", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:56:44Z", "2012-01755", 0, 0, "0900006480fa6ff0"], ["FDA-2011-N-0003-0070", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor's Name", "Rule", "Final Rule", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T15:05:48Z", "2012-01756", 0, 0, "0900006480fa6ff4"], ["FDA-2011-N-0003-0066", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Danofloxacin", "Rule", "Final Rule", "2012-01-27T05:00:00Z", 2012, 1, null, null, "2012-01-27T14:27:44Z", "2012-01743", 0, 0, "0900006480fa6f98"], ["FDA-2011-N-0003-0061", "FDA", "FDA-2011-N-0003", "reedom of Information Summary NADA 141-203 Deracoxib", "Supporting & Related Material", "Freedom of Information Summary", "2012-01-26T05:00:00Z", 2012, 1, null, null, "2012-01-26T14:22:22Z", null, 0, 0, "0900006480fa50c0"], ["FDA-2011-N-0003-0060", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Deracoxib", "Rule", "Final Rule", "2012-01-26T05:00:00Z", 2012, 1, null, null, "2012-01-26T14:09:02Z", "2012-01622", 0, 0, "0900006480fa5564"], ["FDA-2011-N-0003-0058", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Spray", "Rule", "Final Rule", "2012-01-25T05:00:00Z", 2012, 1, "2012-01-25T05:00:00Z", null, "2012-01-25T21:11:07Z", "2012-01501", 0, 0, "0900006480fa3c14"], ["FDA-2011-N-0003-0059", "FDA", "FDA-2011-N-0003", "Gentamicin Topical Spray (gentamicin sulfate, betamethasone valerate- ANADA 200-416; Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2012-01-25T05:00:00Z", 2012, 1, null, null, "2012-01-25T21:52:45Z", null, 0, 0, "0900006480fa4961"], ["FDA-2011-N-0003-0057", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary ANDA 200-318 Bimectin Pour-On (Ivermectin)", "Supporting & Related Material", "Reference (internal unless indicated)", "2011-12-29T05:00:00Z", 2011, 12, null, null, "2011-12-29T14:03:11Z", null, 0, 0, "0900006480f8ad17"], ["FDA-2011-N-0003-0056", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution", "Rule", "Final Rule", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", null, "2011-12-29T13:58:17Z", "2011-33382", 0, 0, "0900006480f8acdf"], ["FDA-2011-N-0003-0054", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Monensin", "Rule", "Final Rule", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:06:14Z", "2011-32427", 0, 0, "0900006480f87099"], ["FDA-2011-N-0003-0055", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor; Zinc Gluconate", "Rule", "Final Rule", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:32:43Z", "2011-32591", 0, 0, "0900006480f87170"], ["FDA-2011-N-0003-0052", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Cyclosporine", "Rule", "Final Rule", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2011-12-20T15:34:59Z", "2011-32526", 0, 0, "0900006480f864a7"], ["FDA-2011-N-0003-0053", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-329 Cyclosporine", "Supporting & Related Material", "Freedom of Information Summary", "2011-12-20T05:00:00Z", 2011, 12, null, null, "2011-12-20T17:17:34Z", null, 0, 0, "0900006480f86905"], ["FDA-2011-N-0003-0049", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-325 Incurin (Estriol)", "Supporting & Related Material", "Freedom of Information Summary", "2011-12-16T05:00:00Z", 2011, 12, null, null, "2011-12-16T18:43:16Z", null, 0, 0, "0900006480f843e3"], ["FDA-2011-N-0003-0048", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Estriol", "Rule", "Final Rule", "2011-12-16T05:00:00Z", 2011, 12, "2011-12-16T05:00:00Z", null, "2011-12-16T18:28:06Z", "2011-32214", 0, 0, "0900006480f84681"], ["FDA-2011-N-0003-0050", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs: Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension", "Rule", "Final Rule", "2011-12-16T05:00:00Z", 2011, 12, "2011-12-16T05:00:00Z", null, "2011-12-16T19:26:27Z", "2011-32226", 0, 0, "0900006480f846b9"], ["FDA-2011-N-0003-0051", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-330 EASOTIC", "Supporting & Related Material", "Freedom of Information Summary", "2011-12-16T05:00:00Z", 2011, 12, null, null, "2011-12-20T17:21:00Z", null, 0, 0, "0900006480f844a8"], ["FDA-2011-N-0003-0045", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary NADA 141-064 Pulmotil 90 Tilmicosin", "Supporting & Related Material", "Reference (internal unless indicated)", "2011-12-09T05:00:00Z", 2011, 12, null, null, "2011-12-09T18:12:30Z", null, 0, 0, "0900006480f7f1b7"], ["FDA-2011-N-0003-0046", "FDA", "FDA-2011-N-0003", "Enviromental Risk Assessment NADA 141-064", "Supporting & Related Material", "Reference (internal unless indicated)", "2011-12-09T05:00:00Z", 2011, 12, null, null, "2011-12-09T18:16:50Z", null, 0, 0, "0900006480f7f1b9"], ["FDA-2011-N-0003-0044", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in AnimalFeeds: Tilmicosin", "Rule", "Final Rule", "2011-12-09T05:00:00Z", 2011, 12, null, null, "2011-12-09T16:06:45Z", "2011-31613", 0, 0, "0900006480f7edc7"], ["FDA-2011-N-0003-0047", "FDA", "FDA-2011-N-0003", "Finding of No Significant Impact (FONSI) - NADA 141-064", "Supporting & Related Material", "Reference (internal unless indicated)", "2011-12-09T05:00:00Z", 2011, 12, null, null, "2011-12-09T18:21:05Z", null, 0, 0, "0900006480f7f1bd"], ["FDA-2011-N-0003-0043", "FDA", "FDA-2011-N-0003", "Eprinomectin Extended- Release Injectable Parasiticide for Cattle NADA 141-327 - Environmental Impact Assessment", "Supporting & Related Material", "Environmental Assessment", "2011-12-06T05:00:00Z", 2011, 12, null, null, "2011-12-06T21:48:41Z", null, 0, 0, "0900006480f7c8c5"], ["FDA-2011-N-0003-0042", "FDA", "FDA-2011-N-0003", "Eprinomectin Extended- Release Injectable Parasiticide for Cattle  NADA 141-327- Finding of no Significant Impact", "Supporting & Related Material", "Finding of no Significant Impact", "2011-12-06T05:00:00Z", 2011, 12, null, null, "2011-12-06T21:39:57Z", null, 0, 0, "0900006480f7c8c4"], ["FDA-2011-N-0003-0041", "FDA", "FDA-2011-N-0003", "LONGRANGE (eprinomectin) Extended- Release Injectable Parasiticide NADA 141-327- Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2011-12-05T05:00:00Z", 2011, 12, null, null, "2011-12-05T16:17:41Z", null, 0, 0, "0900006480f7a085"], ["FDA-2011-N-0003-0040", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs; Eprinomectin", "Rule", "Final Rule", "2011-11-25T05:00:00Z", 2011, 11, "2011-11-25T05:00:00Z", null, "2011-11-25T14:20:46Z", "2011-30328", 0, 0, "0900006480f73670"], ["FDA-2011-N-0003-0039", "FDA", "FDA-2011-N-0003", "Animal Drugs, Feeds, and Related Products; Eprinomectin; N-Methyl-2-Pyrrolidone", "Rule", "Final Rule", "2011-11-25T05:00:00Z", 2011, 11, null, null, "2011-11-25T14:23:01Z", "2011-30329", 0, 0, "0900006480f73650"], ["FDA-2011-N-0003-0037", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin; Tylosin", "Rule", "Final Rule", "2011-10-20T04:00:00Z", 2011, 10, "2011-10-20T04:00:00Z", null, "2011-10-20T14:02:09Z", "2011-27139", 0, 0, "0900006480f56b31"], ["FDA-2011-N-0003-0038", "FDA", "FDA-2011-N-0003", "Heifermax 500 Plus Rumensin and Tylan (melengestrol acetate plus monensin and tylosin phosphate) ANDA 200-375 - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2011-10-20T04:00:00Z", 2011, 10, null, null, "2011-12-05T17:13:59Z", null, 0, 0, "0900006480f56c9a"], ["FDA-2011-N-0003-0035", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin", "Rule", "Final Rule", "2011-09-30T04:00:00Z", 2011, 9, "2011-09-30T04:00:00Z", null, "2011-09-30T13:05:07Z", "2011-25220", 0, 0, "0900006480f45b6a"], ["FDA-2011-N-0003-0036", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary ANDA 200-422 Heifermax 500 plus  Rumensin", "Other", "Freedom of Information Summary (No Federal Register Publication)", "2011-09-30T04:00:00Z", 2011, 9, "2011-09-30T04:00:00Z", null, "2011-09-30T13:13:51Z", null, 0, 0, "0900006480f4344f"], ["FDA-2011-N-0003-0034", "FDA", "FDA-2011-N-0003", "Tylomed-WS  (tylosin tartrate soluble powder) ANDA 200-455 - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2011-09-23T04:00:00Z", 2011, 9, null, null, "2011-12-05T17:16:18Z", null, 0, 0, "0900006480f28610"], ["FDA-2011-N-0003-0033", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Tylosin", "Rule", "Final Rule", "2011-09-23T04:00:00Z", 2011, 9, "2011-09-23T04:00:00Z", null, "2011-09-23T13:49:15Z", "2011-24461", 0, 0, "0900006480f28536"], ["FDA-2011-N-0003-0031", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Gamithromycin", "Rule", "Final Rule", "2011-09-19T04:00:00Z", 2011, 9, "2011-09-19T04:00:00Z", null, "2011-09-19T16:38:18Z", "2011-23874", 0, 0, "0900006480f22065"], ["FDA-2011-N-0003-0030", "FDA", "FDA-2011-N-0003", "Tolerances for Residues of New Animal Drugs in Food: Progesterone", "Rule", "Final Rule", "2011-09-19T04:00:00Z", 2011, 9, "2011-09-19T04:00:00Z", null, "2011-09-19T16:31:42Z", "2011-23867", 0, 0, "0900006480f220a7"], ["FDA-2011-N-0003-0032", "FDA", "FDA-2011-N-0003", "Zactran (gamithomycin injectable solution) (NADA 141-328) - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2011-09-19T04:00:00Z", 2011, 9, null, null, "2011-12-05T17:18:47Z", null, 0, 0, "0900006480f227f4"], ["FDA-2011-N-0003-0028", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin", "Rule", "Final Rule", "2011-09-19T04:00:00Z", 2011, 9, "2011-09-19T04:00:00Z", null, "2011-09-19T16:03:53Z", "2011-23865", 0, 0, "0900006480f22114"], ["FDA-2011-N-0003-0029", "FDA", "FDA-2011-N-0003", "Bimectin Injectable Solution (ivermectin) (ANADA 200-447) - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2011-09-19T04:00:00Z", 2011, 9, null, null, "2011-12-05T17:20:22Z", null, 0, 0, "0900006480f22608"], ["FDA-2011-N-0003-0027", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, etc.; Correcting Amendments", "Rule", "Correction", "2011-08-25T04:00:00Z", 2011, 8, null, null, "2011-08-25T13:40:34Z", "2011-21721", 0, 0, "0900006480eee4b8"], ["FDA-2011-N-0003-0026", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Change of Sponsor; Chlortetracycline; Sulfamethazine", "Rule", "Final Rule", "2011-08-11T04:00:00Z", 2011, 8, null, null, "2011-08-11T13:46:29Z", "2011-20404", 0, 0, "0900006480edde3b"], ["FDA-2011-N-0003-0025", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor; Moxidectin", "Rule", "Final Rule", "2011-08-09T04:00:00Z", 2011, 8, "2011-08-09T04:00:00Z", null, "2011-08-09T14:46:08Z", "2011-20182", 0, 0, "0900006480edbacf"], ["FDA-2011-N-0003-0023", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Amprolium", "Rule", "Final Rule", "2011-07-12T04:00:00Z", 2011, 7, "2011-07-12T04:00:00Z", null, "2011-07-12T14:34:01Z", "2011-17465", 0, 0, "0900006480ec062c"], ["FDA-2011-N-0003-0024", "FDA", "FDA-2011-N-0003", "Ampromed P (amprolium) (ANADA 200-488) -  Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2011-07-12T04:00:00Z", 2011, 7, null, null, "2011-12-05T17:21:57Z", null, 0, 0, "0900006480ec0a71"], ["FDA-2011-N-0003-0022", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor's Name and Address", "Rule", "Final Rule", "2011-07-11T04:00:00Z", 2011, 7, "2011-07-11T04:00:00Z", null, "2011-07-11T13:50:45Z", "2011-17292", 0, 0, "0900006480ebef6a"], ["FDA-2011-N-0003-0021", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2011-07-08T04:00:00Z", 2011, 7, "2011-07-08T04:00:00Z", null, "2011-07-08T19:06:59Z", "2011-17151", 0, 0, "0900006480ebcfab"], ["FDA-2011-N-0003-0020", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor's Address", "Rule", "Final Rule", "2011-07-06T04:00:00Z", 2011, 7, "2011-07-06T04:00:00Z", null, "2011-07-06T18:50:24Z", "2011-16845", 0, 0, "0900006480eba135"], ["FDA-2011-N-0003-0019", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Amprolium", "Rule", "Final Rule", "2011-07-01T04:00:00Z", 2011, 7, "2011-07-01T04:00:00Z", null, "2011-07-01T14:40:14Z", "2011-16501", 0, 0, "0900006480eb82fd"], ["FDA-2011-N-0003-0017", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor-Diphtheria Toxoid Conjugate", "Rule", "NFR-Notice of Final Rule", "2011-05-13T04:00:00Z", 2011, 5, "2011-05-13T04:00:00Z", null, "2011-05-13T12:55:58Z", "2011-11762", 0, 0, "0900006480c79e08"], ["FDA-2011-N-0003-0018", "FDA", "FDA-2011-N-0003", "Freedom Of Information Summary - [NADA 141-322]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-05-13T04:00:00Z", 2011, 5, null, null, "2011-05-13T13:04:01Z", null, 0, 0, "0900006480c79711"], ["FDA-2011-N-0003-0015", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Enrofloxacin", "Rule", "NFR-Notice of Final Rule", "2011-04-22T04:00:00Z", 2011, 4, "2011-04-22T04:00:00Z", null, "2011-04-22T13:02:12Z", "2011-09765", 0, 0, "0900006480c35d41"], ["FDA-2011-N-0003-0016", "FDA", "FDA-2011-N-0003", "Freedom Of Information Summary [ NADA 141-068]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-04-22T04:00:00Z", 2011, 4, null, null, "2011-04-22T13:13:04Z", null, 0, 0, "0900006480c35ae1"], ["FDA-2011-N-0003-0013", "FDA", "FDA-2011-N-0003", "Attachment - Veterinary insert for Product carton - [Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-04-20T04:00:00Z", 2011, 4, null, null, "2011-04-20T17:24:19Z", null, 0, 0, "0900006480c33a6c"], ["FDA-2011-N-0003-0014", "FDA", "FDA-2011-N-0003", "Attachment - Owner insert for dispensing envelope - [Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-04-20T04:00:00Z", 2011, 4, null, null, "2011-04-20T17:28:01Z", null, 0, 0, "0900006480c33a9b"], ["FDA-2011-N-0003-0012", "FDA", "FDA-2011-N-0003", "Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-04-05T04:00:00Z", 2011, 4, null, null, "2011-04-05T14:04:47Z", null, 0, 0, "0900006480c1b79a"], ["FDA-2011-N-0003-0011", "FDA", "FDA-2011-N-0003", "Oral Dosages Form New Animal Drugs: Robenacoxib", "Rule", "NFR-Notice of Final Rule", "2011-04-05T04:00:00Z", 2011, 4, "2011-04-05T04:00:00Z", null, "2011-04-05T13:54:22Z", "2011-08053", 0, 0, "0900006480c1bc56"], ["FDA-2011-N-0003-0009", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments", "Rule", "NCR-Notice of Correction", "2011-03-29T04:00:00Z", 2011, 3, "2011-03-29T04:00:00Z", null, "2011-03-29T13:29:20Z", "2011-07313", 0, 0, "0900006480c1279e"], ["FDA-2011-N-0003-0010", "FDA", "FDA-2011-N-0003", "Freedom Of Information Summary - 200-026 [PENNOX 343]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-03-29T04:00:00Z", 2011, 3, null, null, "2011-03-29T13:44:53Z", null, 0, 0, "0900006480c12b4e"], ["FDA-2011-N-0003-0007", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Oxytetracycline", "Rule", "NFR-Notice of Final Rule", "2011-03-28T04:00:00Z", 2011, 3, "2011-03-28T04:00:00Z", null, "2011-03-28T14:44:26Z", "2011-07216", 0, 0, "0900006480c11e79"], ["FDA-2011-N-0003-0008", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Arsanilate Sodium; Sulfaethoxypyridazine", "Rule", "NFR-Notice of Final Rule", "2011-03-28T04:00:00Z", 2011, 3, "2011-03-28T04:00:00Z", null, "2011-03-28T14:56:22Z", "2011-07214", 0, 0, "0900006480c11e7a"], ["FDA-2011-N-0003-0006", "FDA", "FDA-2011-N-0003", "Tolerances for Residues of New Animal Drugs in Food: 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters, etc.; Correcting Amendments", "Rule", "NFR-Notice of Final Rule", "2011-03-25T04:00:00Z", 2011, 3, "2011-03-25T04:00:00Z", null, "2011-03-25T15:07:49Z", "2011-06796", 0, 0, "0900006480c10d09"], ["FDA-2011-N-0003-0004", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Spinosad and Milbemycin Oxime", "Rule", "NFR-Notice of Final Rule", "2011-03-08T05:00:00Z", 2011, 3, "2011-03-08T05:00:00Z", null, "2011-03-08T16:02:16Z", "2011-05144", 0, 0, "0900006480c0323d"], ["FDA-2011-N-0003-0005", "FDA", "FDA-2011-N-0003", "Freedom Of Information Summary- 141-321 [TRIFEXIS Spinosad and Milbemycin oxime Chewable Tablets Dogs]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-03-08T05:00:00Z", 2011, 3, null, null, "2011-03-08T16:19:23Z", null, 0, 0, "0900006480c02cd8"], ["FDA-2011-N-0003-0003", "FDA", "FDA-2011-N-0003", "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications: Phenylbutazone; Pyrantel; Tylosin", "Notice", "NFR-Notice of Final Rule", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T17:54:11Z", "2011-04546", 0, 0, "0900006480bfcca3"], ["FDA-2011-N-0003-0001", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Masitinib", "Rule", "NFR-Notice of Final Rule", "2011-02-04T05:00:00Z", 2011, 2, "2011-02-04T05:00:00Z", null, "2011-02-04T15:32:40Z", "2011-2519", 0, 0, "0900006480bdbad8"]], "truncated": false, "filtered_table_rows_count": 80, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2011-N-0003"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003", "results": [{"value": "FDA", "label": "FDA", "count": 80, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2011-N-0003", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003", "results": [{"value": "Rule", "label": "Rule", "count": 45, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&document_type=Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 31, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003", "results": [{"value": 2011, "label": 2011, "count": 56, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&posted_year=2011", "selected": false}, {"value": 2012, "label": 2012, "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&posted_year=2012", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2011-N-0003&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 168.03176095709205, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}